vs
安霸（AMBA）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是安霸的1.9倍（$207.3M vs $108.5M），安霸净利率更高（-13.9% vs -62.0%，领先48.1%），安霸同比增速更快（31.2% vs 25.9%），安霸自由现金流更多（$31.4M vs $-100.8M），过去两年安霸的营收复合增速更高（45.0% vs 38.0%）
安霸是美国无晶圆厂半导体设计企业，专注于低功耗高清、超高清视频压缩、图像处理及计算机视觉处理器研发。其芯片产品广泛应用于视频安防、高级驾驶辅助系统、电子后视镜、行车记录仪、驾驶舱内监测、自动驾驶、机器人等多元人机视觉场景。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
AMBA vs RARE — 直观对比
营收规模更大
RARE
是对方的1.9倍
$108.5M
营收增速更快
AMBA
高出5.3%
25.9%
净利率更高
AMBA
高出48.1%
-62.0%
自由现金流更多
AMBA
多$132.2M
$-100.8M
两年增速更快
AMBA
近两年复合增速
38.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $108.5M | $207.3M |
| 净利润 | $-15.1M | $-128.6M |
| 毛利率 | 59.6% | — |
| 营业利润率 | -15.0% | -54.7% |
| 净利率 | -13.9% | -62.0% |
| 营收同比 | 31.2% | 25.9% |
| 净利润同比 | 37.2% | 3.5% |
| 每股收益（稀释后） | $-0.35 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMBARARE
| Q4 25 | $108.5M | $207.3M | ||
| Q3 25 | $95.5M | $159.9M | ||
| Q2 25 | $85.9M | $166.5M | ||
| Q1 25 | $84.0M | $139.3M | ||
| Q4 24 | $82.7M | $164.6M | ||
| Q3 24 | $63.7M | $139.5M | ||
| Q2 24 | $54.5M | $147.0M | ||
| Q1 24 | $51.6M | $108.8M |
净利润AMBARARE
| Q4 25 | $-15.1M | $-128.6M | ||
| Q3 25 | $-20.0M | $-180.4M | ||
| Q2 25 | $-24.3M | $-115.0M | ||
| Q1 25 | $-20.2M | $-151.1M | ||
| Q4 24 | $-24.1M | $-133.2M | ||
| Q3 24 | $-34.9M | $-133.5M | ||
| Q2 24 | $-37.9M | $-131.6M | ||
| Q1 24 | $-60.6M | $-170.7M |
毛利率AMBARARE
| Q4 25 | 59.6% | — | ||
| Q3 25 | 58.9% | — | ||
| Q2 25 | 60.0% | — | ||
| Q1 25 | 60.0% | — | ||
| Q4 24 | 60.6% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 60.9% | — | ||
| Q1 24 | 59.8% | — |
营业利润率AMBARARE
| Q4 25 | -15.0% | -54.7% | ||
| Q3 25 | -23.0% | -106.9% | ||
| Q2 25 | -30.1% | -64.8% | ||
| Q1 25 | -30.2% | -102.6% | ||
| Q4 24 | -30.9% | -74.3% | ||
| Q3 24 | -56.9% | -94.6% | ||
| Q2 24 | -72.4% | -79.1% | ||
| Q1 24 | -80.8% | -151.9% |
净利率AMBARARE
| Q4 25 | -13.9% | -62.0% | ||
| Q3 25 | -20.9% | -112.8% | ||
| Q2 25 | -28.3% | -69.0% | ||
| Q1 25 | -24.1% | -108.5% | ||
| Q4 24 | -29.1% | -80.9% | ||
| Q3 24 | -54.8% | -95.7% | ||
| Q2 24 | -69.6% | -89.5% | ||
| Q1 24 | -117.4% | -156.8% |
每股收益（稀释后）AMBARARE
| Q4 25 | $-0.35 | $-1.28 | ||
| Q3 25 | $-0.47 | $-1.81 | ||
| Q2 25 | $-0.58 | $-1.17 | ||
| Q1 25 | $-0.48 | $-1.57 | ||
| Q4 24 | $-0.58 | $-1.34 | ||
| Q3 24 | $-0.85 | $-1.40 | ||
| Q2 24 | $-0.93 | $-1.52 | ||
| Q1 24 | $-1.51 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $174.1M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $590.1M | $-80.0M |
| 总资产 | $751.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMBARARE
| Q4 25 | $174.1M | $421.0M | ||
| Q3 25 | $142.7M | $202.5M | ||
| Q2 25 | $141.3M | $176.3M | ||
| Q1 25 | $144.6M | $127.1M | ||
| Q4 24 | $127.1M | $174.0M | ||
| Q3 24 | $153.9M | $150.6M | ||
| Q2 24 | $131.8M | $480.7M | ||
| Q1 24 | $144.9M | $112.3M |
股东权益AMBARARE
| Q4 25 | $590.1M | $-80.0M | ||
| Q3 25 | $576.5M | $9.2M | ||
| Q2 25 | $572.7M | $151.3M | ||
| Q1 25 | $561.4M | $144.2M | ||
| Q4 24 | $554.3M | $255.0M | ||
| Q3 24 | $547.6M | $346.8M | ||
| Q2 24 | $555.4M | $432.4M | ||
| Q1 24 | $559.9M | $140.3M |
总资产AMBARARE
| Q4 25 | $751.9M | $1.5B | ||
| Q3 25 | $706.4M | $1.2B | ||
| Q2 25 | $701.9M | $1.3B | ||
| Q1 25 | $689.0M | $1.3B | ||
| Q4 24 | $670.8M | $1.5B | ||
| Q3 24 | $650.3M | $1.5B | ||
| Q2 24 | $638.7M | $1.6B | ||
| Q1 24 | $657.7M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $31.4M | $-100.8M |
| 自由现金流率自由现金流/营收 | 29.0% | -48.6% |
| 资本支出强度资本支出/营收 | 2.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $64.3M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流AMBARARE
| Q4 25 | $34.3M | $-99.8M | ||
| Q3 25 | $5.5M | $-91.4M | ||
| Q2 25 | $14.8M | $-108.3M | ||
| Q1 25 | $25.4M | $-166.5M | ||
| Q4 24 | $6.6M | $-79.3M | ||
| Q3 24 | $16.7M | $-67.0M | ||
| Q2 24 | $-15.0M | $-77.0M | ||
| Q1 24 | $-4.0M | $-190.7M |
自由现金流AMBARARE
| Q4 25 | $31.4M | $-100.8M | ||
| Q3 25 | $1.4M | $-92.7M | ||
| Q2 25 | $10.2M | $-110.7M | ||
| Q1 25 | $21.2M | $-167.8M | ||
| Q4 24 | $4.1M | $-79.5M | ||
| Q3 24 | $14.2M | $-68.6M | ||
| Q2 24 | $-16.1M | $-79.0M | ||
| Q1 24 | $-6.0M | $-193.9M |
自由现金流率AMBARARE
| Q4 25 | 29.0% | -48.6% | ||
| Q3 25 | 1.4% | -58.0% | ||
| Q2 25 | 11.9% | -66.5% | ||
| Q1 25 | 25.3% | -120.5% | ||
| Q4 24 | 5.0% | -48.3% | ||
| Q3 24 | 22.2% | -49.2% | ||
| Q2 24 | -29.5% | -53.7% | ||
| Q1 24 | -11.6% | -178.2% |
资本支出强度AMBARARE
| Q4 25 | 2.7% | 0.5% | ||
| Q3 25 | 4.3% | 0.8% | ||
| Q2 25 | 5.3% | 1.5% | ||
| Q1 25 | 5.0% | 1.0% | ||
| Q4 24 | 3.0% | 0.1% | ||
| Q3 24 | 4.0% | 1.2% | ||
| Q2 24 | 2.1% | 1.4% | ||
| Q1 24 | 3.7% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMBA
| TW | $76.0M | 70% |
| Asia Pacific Other Than Taiwan | $20.2M | 19% |
| North America Other Than United States | $7.4M | 7% |
| Other | $5.0M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
